ANNUAL RESULTS
Dr. Reddy's Laboratories Ltd.
BSE
Apr 30
1183.00
+6.75 (+ 0.57%)
Volume
44575
Prev. Close
1176.25
Open Price
1176.25
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
1183.90
+7.90 (+ 0.67%)
Volume
1604442
Prev. Close
1176.00
Open Price
1176.20
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Annual Results
for the last 5 years.
ISIN No
|
INE089A01031
|
Market Cap. ( ₹ in Cr. )
|
98791.17
|
P/BV
|
3.21
|
Book Value ( ₹ )
|
368.50
|
BSE Code
|
500124
|
52 Week High/Low ( ₹ )
|
1421/1020
|
FV/ML
|
1/1
|
P/E(X)
|
17.71
|
NSE Code
|
DRREDDYEQ
|
Book Closure
|
28/10/2024
|
EPS ( ₹ )
|
66.84
|
Div Yield (%)
|
0.68
|
(₹ in Crs.)
Net Sales/Income from operations | 19404.10 | 16298.90 | 14315.30 | 13329.30 | 11803.00 |
Other Operating Income | 79.70 | 663.60 | 89.90 | 19.80 | 47.40 |
Total Income From Operations | 19483.80 | 16962.50 | 14405.20 | 13349.10 | 11850.40 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 3291.50 | 3161.40 | 3378.40 | 3266.30 | 2556.50 |
Purchase of Traded Goods | 1986.60 | 1779.30 | 2057.10 | 1252.30 | 1117.20 |
Increase/Decrease in Stocks | -238.80 | 129.50 | -389.60 | -395.60 | -99.90 |
Employees Cost | 3085.70 | 2832.60 | 2434.60 | 2270.10 | 2030.20 |
Depreciation | 975.60 | 923.20 | 814.30 | 835.00 | 789.20 |
Admin. And Selling Expenses | 0.00 | 4839.80 | 4320.80 | 3804.20 | 0.00 |
Provisions And Contingencies | 26.00 | 5.10 | 9.80 | 15.00 | 0.00 |
Other Expenses | 5406.40 | 0.00 | 0.00 | 0.00 | 3376.80 |
Total Expenses | 14533.00 | 13670.90 | 12625.40 | 11047.30 | 9770.00 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 4950.80 | 3291.60 | 1779.80 | 2301.80 | 2080.40 |
Other Income | 862.30 | 591.30 | 482.00 | 801.10 | 743.20 |
P/L Before Interest, Excpt. Items & Tax | 5813.10 | 3882.90 | 2261.80 | 3102.90 | 2823.60 |
Interest | 21.80 | 16.90 | 38.00 | 46.70 | 47.80 |
P/L Before Exceptional Items & Tax | 5791.30 | 3866.00 | 2223.80 | 3056.20 | 2775.80 |
P/L Before Tax | 5791.30 | 3866.00 | 2223.80 | 3056.20 | 2775.80 |
Tax | 1449.30 | 1253.20 | 600.60 | 869.80 | -161.90 |
P/L After Tax from Ordinary Activities | 4342.00 | 2612.80 | 1623.20 | 2186.40 | 2937.70 |
Net Profit/Loss For the Period | 4342.00 | 2612.80 | 1623.20 | 2186.40 | 2937.70 |
| | | | | |
Equity Share Capital | 83.40 | 83.30 | 83.20 | 83.20 | 83.10 |
Reserves And Surplus | 24157.40 | 20390.90 | 18253.00 | 16900.50 | 15108.80 |
Equity Dividend Rate | 800.00 | 800.00 | 600.00 | 500.00 | 500.00 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 260.95 | 157.37 | 97.85 | 131.84 | 177.23 |
Diluted EPS (Rs.) | 260.46 | 157.03 | 97.58 | 131.46 | 176.88 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 260.95 | 157.37 | 97.85 | 131.84 | 177.23 |
Diluted EPS (Rs.) | 260.46 | 157.03 | 97.58 | 131.46 | 176.88 |
| | | | | |
PBITOE Margin (%) | 25.40 | 19.40 | 12.35 | 17.24 | 17.55 |
PBTE Margin (%) | 29.72 | 22.79 | 15.43 | 22.89 | 23.42 |
PBT Margin (%) | 29.72 | 22.79 | 15.43 | 22.89 | 23.42 |
PAT Margin (%) | 22.28 | 15.40 | 11.26 | 16.37 | 24.78 |